|
ACXP Acurx Pharmaceuticals Inc 1736243 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,680,982.00 |
| Balance Sheet |
|
Current Assets
|
$6,157,858.00 |
|
Assets
|
$9,539,952.00 |
|
Current Liabilities
|
$2,526,809.00 |
|
Liabilities
|
$2,526,809.00 |
|
Equity
|
$7,013,143.00 |
|
Shares Out
|
3389106.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,407,533.00 |
| Market Analysis |
Market Cap
|
$4,812,530.52 |
|
Price
|
$1.44 |
|
BVPS
|
2.07 |
|
PB
|
0.69 |
|
EPS
|
-0.62 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
| Apr |
May |
Jun |
| 2026-03-13 |
-0.73 |
|
|
2026-05-12 |
-0.62 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-1.89 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-1.23 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACXP documents filed with the SEC.
ACXP Filings
Clear
